Atlas Trials

Proof-of-concept to Evaluate the Efficacy and Safety of Prednisone in Idiosyncratic Hepatotoxicity

Clinical trial NCT06251232 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06251232
Sponsor
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
HepatotoxicityIdiosyncratic Drug EffectPrednisone
Start date
2024-05-01
Primary completion
2027-12-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.